Involvement of apoptosis in mitomycin C hypersensitivity of Chinese hamster cell mutants

Biochemical Pharmacology

Volumn 59, Issue 9, 2000, Pages 1101-1107

  Papouli, Efterpi ^a   Lafon, Corinne ^a   Valette, Annie ^a   Zdzienicka, Malgorzata Z ^b   Defais, Martine ^a   Larminat, Florence ^a  

^a INSTITUT DE PHARMACOLOGIE ET DE BIOLOGIE STRUCTURALE   (France)

^b LEIDEN UNIVERSITY   (Netherlands)

Author keywords

Apoptosis; DNA damage; Mitomycin C; Mitomycin C hypersensitivity

Indexed keywords

MITOMYCIN C; VINCRISTINE;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL CYCLE; CELL LINE; CELL MUTANT; CHO CELL; CONTROLLED STUDY; CYTOTOXICITY; DRUG HYPERSENSITIVITY; IN VITRO STUDY; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; APOPTOSIS; CELL CYCLE; CELLS, CULTURED; CRICETINAE; CRICETULUS; MITOMYCIN; MUTATION;

EID: 0033961190     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-2952(00)00234-3     Document Type: Article

References (26)

1. Dorr RT and Von Hoff DD, Mitomycin C. In: Cancer Chemotherapy Handbook 2nd Edn. (Eds. Dorr RT and Von Hoff DD), pp. 717-726. Appleton & Lange, East Norwalk, 1994.
2. Tomasz M., Lipman R. Reductive metabolism and alkylation activity of mitomycin C induced by rat liver microsomes. Biochemistry. 20:1981;5056-5061.
3. Tomasz M. Mitomycin C Small, fast and deadly (but very selective) . Chem Biol. 2:1995;575-579.
4. Doll D.C., Weiss R.B., Issell B.F. Mitomycin C Ten years after approval for marketing . J Clin Oncol. 3:1985;276-286.
5. Plooy A.C., van Dijk M., Berends F., Lohman P.H. Formation and repair of DNA interstrand cross-links in relation to cytotoxicity and unscheduled DNA synthesis induced in control and mutant human cells treated with cis-diamminedichloroplatinum(II). Cancer Res. 45:1985;4178-4184.
6. Demarcq C., Bunch R.T., Creswell D., Eastman A. The role of cell cycle progression in cisplatin-induced apoptosis in Chinese hamster ovary cells. Cell Growth Differ. 5:1994;983-993.
7. Zdzienicka M.Z., Simons J.W. Mutagen-sensitive cell lines are obtained with a high frequency in V79 Chinese hamster cells. Mutat Res. 194:1987;239-249.
8. Jones N.J. Genetic analysis of mitomycin C-hypersensitive Chinese hamster cell mutants. Mutagenesis. 9:1994;477-482.
9. Telleman P., Overkamp W.J., van Wessel N., Studzian K., Wetselaar L., Natarajan A.T., Zdzienicka M.Z. A new complementation group of mitomycin C-hypersensitive Chinese hamster cell mutants that closely resembles the phenotype of Fanconi anemia cells. Cancer Res. 55:1995;3412-3416.
10. Zdzienicka M.Z., Arwert F., Neuteboom I., Rooimans M., Simons J.W. Chinese hamster V79 cell mutant V-H4 is phenotypically like Fanconi anemia cells. Somat Cell Mol Genet. 6:1990;575-581.
11. Overkamp W.J., Rooimans M.A., Neuteboom I., Telleman P., Arwert F., Zdzienicka M.Z. Genetic diversity of mitomycin C-hypersensitive Chinese hamster cell mutants A new complementation group with chromosomal instability . Somat Cell Mol Genet. 19:1993;431-437.
12. Arwert F., Rooimans M., Westerfeld A., Simons J.W., Zdzienicka M.Z. The Chinese hamster cell mutant V-H4 is homologous to Fanconi anemia (complementation group A). Cytogenet Cell Genet. 56:1991;23-26.
13. Chaung W., Mi L.J., Boorstein R.J. The p53 status of Chinese hamster V79 cells frequently used for studies on DNA damage and DNA repair. Nucleic Acids Res. 25:1997;992-994.
14. Larminat F., Cambois G., Zdzienicka M.Z., Defais M. Lack of correlation between repair of DNA interstrand cross-links and hypersensitivity of hamster cells towards mitomycin C and cisplatin. FEBS Lett. 437:1998;97-100.
15. Dulhanty A.M., Li M., Whitmore G.F. Isolation of Chinese hamster ovary cell mutants deficient in excision repair and mitomycin C bioactivation. Cancer Res. 49:1989;117-122.
16. Carr A.M., Hoekstra M.K. The cellular responses to DNA damage. Trends Cell Biol. 5:1995;32-40.
17. Dutrillaux B., Aurias A., Dutrillaux A.M., Briot D., Prieur M. The cell cycle of lymphocytes in Fanconi anemia. Hum Genet. 62:1982;327-332.
18. Kupfer G.M., Yamashita T., Naf D., Suliman A., Asano S., D'Andrea A.D. The Fanconi anemia polypeptide, FAC, binds to the cyclin-dependent kinase, cdc2. Blood. 90:1997;1047-1054.
19. Heinrich M.C., Hoatlin M.E., Zigler A.J., Silvey K.V., Bakke A.C., Keeble W.W., Zhi Y., Reifsteck C.A., Grompe M., Brown M.G., Magenis R.E., Olson S.B., Bagby G.C. DNA cross-linker-induced G2/M arrest in group C Fanconi anemia lymphoblasts reflects normal checkpoint function. Blood. 91:1998;275-287.
20. Lowe S.W., Schmitt E.M., Smith S.W., Osborne B.A., Jacks T. p53 is required for radiation-induced apoptosis in mouse thymocytes. Nature. 362:1993;847-849.
21. Strasser A., Harris A.W., Jacks T., Cory S. DNA damage can induce apoptosis in proliferating lymphoid cells via p53-independent mechanisms inhibitable by Bcl-2. Cell. 79:1994;329-339.
22. Kruyt F.A., Dijkmans L.M., van den Berg T.K., Joenje H. Fanconi anemia genes act to suppress a cross-linker-inducible p53-independent apoptosis pathway in lymphoblastoid cell lines. Blood. 87:1996;938-948.
23. Doroshow J.H. Role of hydrogen peroxide and hydroxyl radical formation in the killing of Ehrlich tumor cells by anticancer quinones. Proc Natl Acad Sci USA. 83:1986;4514-4518.
24. Marathi U.K., Howell S.R., Ashmun R.A., Brent T.P. The Fanconi anemia complementation group C protein corrects DNA interstrand cross-link-specific apoptosis in HSC536N cells. Blood. 88:1996;2298-2305.
25. Monti D., Macchioni S., Guido M., Pagano G., Zatterale A., Calzone R., Cossarizza A., Straface E., Malorni W., Franceschi C. Resistance to apoptosis in Fanconi's anaemia. An ex vivo study in peripheral blood mononuclear cells. FEBS Lett. 16:1997;365-369.
26. Ridet A., Guillouf C., Duchaud E., Cundari E., Fiore M., Moustacchi E., Rosselli F. Deregulated apoptosis is a hallmark of the Fanconi anemia syndrome. Cancer Res. 57:1997;1722-1730.